SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-198029
Filing Date
2014-05-14
Accepted
2014-05-14 07:20:18
Documents
11
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d707700d10q.htm 10-Q 613655
2 EX-31.1 d707700dex311.htm EX-31.1 7773
3 EX-31.2 d707700dex312.htm EX-31.2 7747
4 EX-32.1 d707700dex321.htm EX-32.1 4118
5 EX-32.2 d707700dex322.htm EX-32.2 4078
  Complete submission text file 0001193125-14-198029.txt   3707143

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT cnce-20140331.xml EX-101.INS 440769
7 XBRL TAXONOMY EXTENSION SCHEMA cnce-20140331.xsd EX-101.SCH 32736
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cnce-20140331_cal.xml EX-101.CAL 52917
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cnce-20140331_def.xml EX-101.DEF 113090
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE cnce-20140331_lab.xml EX-101.LAB 304951
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cnce-20140331_pre.xml EX-101.PRE 231570
Mailing Address 99 HAYDEN AVENUE SUITE 500 LEXINGTON MA 02421
Business Address 99 HAYDEN AVENUE SUITE 500 LEXINGTON MA 02421 781-860-0045
CONCERT PHARMACEUTICALS, INC. (Filer) CIK: 0001367920 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36310 | Film No.: 14839190
SIC: 2834 Pharmaceutical Preparations